About
About Avecho
Board & Leadership
TPM
®
Technology
Portfolio
Pipeline
Phase III Trial
Cannabinoids
Pharmaceutical
Animal Health
Manufacturing
Invest
Investor Centre
Media Centre
Contact
Hit enter to search or ESC to close
Retirement of Non-Executive Director
May 28, 2018
Click here to read more
Post navigation
Previous Post
2018 AGM Results
Next Post
Phosphagenics Still Awaits SIAC Arbitration Update
Related Posts
Avecho’s Phase III Clinical Trial for Insomnia Commences
March 26, 2024
March 26, 2024
Phosphagenics Restructures
October 12, 2015
Chairman Resignation
May 12, 2015